What are the Post COVID Blood Tests?

For patients recovering from COVID-19 in Pune and across Maharashtra, a negative test result marks the end of acute illness — but not necessarily the end of the virus's impact on the body. Post-COVID syndrome, also known as Long COVID, affects a clinically significant proportion of recovered patients through persistent symptoms including fatigue, breathlessness, brain fog, and chest discomfort. At healthcare nt sickcare, a NABL-partner diagnostic laboratory established in Aundh, Pune since 2007, post-COVID blood test requests became one of the most common enquiries from 2021 onwards as patients sought to understand what was still happening in their bodies weeks after discharge.

Post-COVID complications include a wide range of organ-level effects — from liver enzyme derangements and kidney function changes to cardiac inflammation and new-onset diabetes — that may be entirely asymptomatic and only detectable through blood investigation. A structured after-COVID test panel is the most evidence-based approach to detecting these complications early, before they progress to more serious clinical conditions. This article provides the complete post-COVID blood test list, explains what each test checks, and outlines the post-COVID diseases and symptoms that warrant urgent investigation.

Post-COVID Syndrome — What Is It and Who Is at Risk?

Post-COVID syndrome is defined by WHO as the persistence of symptoms or development of new symptoms that begin during or after COVID-19 infection, last more than 12 weeks, and are not explained by an alternative diagnosis.

According to a study published by ICMR in the Indian Journal of Medical Research, approximately 17–30% of Indian COVID-19 survivors reported at least one persistent symptom at 3 months post-recovery. Maharashtra, including Pune and Pimpri-Chinchwad, was one of the most heavily affected states during both the Delta and Omicron waves, meaning a substantial number of post-COVID patients in Pune continue to require monitoring and follow-up care. High-risk groups for post-COVID complications include patients who required hospitalisation or oxygen support during acute illness, diabetics, those with hypertension or cardiac disease, and patients who experienced cytokine storm — a severe immune overreaction that causes widespread inflammation and organ involvement.

Our related articles on the coronavirus pandemic in India and its variants and on the long-term effects of coronavirus infection including blood clotting and vaccines provide broader context for post-COVID health monitoring.

Complete Post-COVID Blood Test List

The following tests form the standard post-COVID screening panel recommended by most physicians in India, based on ICMR guidance and clinical practice across Pune's hospital network. Not all tests are required for every patient — your doctor will advise based on severity of acute illness, current symptoms, and comorbidities.

Complete Blood Count — Detecting Anaemia and Immune Abnormalities

The complete blood count (CBC) provides a detailed picture of blood cell populations. Post-COVID, the most clinically relevant findings include low lymphocyte count (lymphopenia), which indicates ongoing immune suppression; low platelet count (thrombocytopenia), which increases bleeding risk; and anaemia, which often underlies persistent fatigue in recovered patients. Normal WBC range is 4,000–11,000 per microlitre; haemoglobin should be above 12 g/dL in women and 13 g/dL in men; platelets should be between 1.5 and 4.5 lakh per microlitre.

Inflammatory Markers — Assessing Residual Inflammation

COVID-19 triggers a systemic inflammatory response that can persist well beyond clinical recovery. The key inflammatory markers to assess include:

• C-Reactive Protein (CRP) — Normal below 6 mg/L. Persistently elevated CRP indicates active inflammation that may be driving ongoing fatigue, joint pain, and breathlessness.
• High-Sensitivity CRP (hs-CRP) — More sensitive measure of low-grade chronic inflammation, useful for cardiac risk stratification post-COVID.
• ESR (Erythrocyte Sedimentation Rate) — Elevated in ongoing inflammation or infection. Usually normalises within 2–3 months post-recovery.
• Serum Ferritin — Normal range 30–400 ng/mL. High ferritin in Long COVID patients reflects chronic hyperferritinaemic inflammation.
• D-Dimer — Normal below 0.5 mg/L. Elevated D-Dimer post-COVID indicates ongoing clotting activation and warrants specialist review to rule out DVT or pulmonary embolism.

Organ Function Tests — Liver, Kidney, and Cardiac Screening

COVID-19 is a multi-organ disease. Even patients who had mild acute illness can develop sub-clinical organ damage detectable only on blood testing. The standard organ function panel post-COVID includes:

• Liver Function Tests (LFT) — Check bilirubin, SGOT, SGPT, alkaline phosphatase, and total protein. Post-COVID hepatitis and drug-induced liver injury (from medications used during treatment) are the two most common causes of deranged LFT post-recovery.
• Kidney Function Tests (KFT) — Assess serum creatinine, blood urea, and eGFR. Acute kidney injury during COVID-19 can leave residual impairment that requires follow-up monitoring, particularly in patients with pre-existing kidney disease.
• Cardiac Biomarkers — Troponin I or T, CK-MB, and NT-proBNP assess post-COVID myocarditis, cardiac inflammation, and heart failure risk. These are particularly important for patients who reported chest pain, palpitations, or breathlessness during or after COVID-19.

Diabetes Profile — Detecting New-Onset Post-COVID Diabetes

COVID-19 is now established as a trigger for new-onset diabetes mellitus, through direct pancreatic beta-cell damage and steroid-induced hyperglycaemia. Even patients with no prior history of diabetes should be screened post-recovery. The diabetes panel includes fasting blood glucose (normal below 100 mg/dL), HbA1c (normal below 5.7%), and insulin levels. A study in The Lancet Diabetes and Endocrinology found a significantly elevated risk of new-onset Type 2 diabetes in COVID-19 survivors at 30-day and 12-month follow-up compared to uninfected controls.

Vitamin and Micronutrient Panel

Nutritional depletion during acute COVID-19 illness — compounded by reduced food intake, inflammatory consumption of nutrients, and prolonged isolation — leaves many patients deficient in key vitamins and minerals. Post-COVID testing should include Vitamin D3 (normal 30–100 ng/mL), Vitamin B12 (normal 200–900 pg/mL), folic acid, and zinc. Deficiencies in Vitamin D and B12 are among the most common findings in Long COVID patients in India and are directly associated with fatigue, cognitive impairment, and mood disturbances.

Thyroid Function Tests

Post-COVID thyroiditis — inflammation of the thyroid gland triggered by the immune response to SARS-CoV-2 — has been documented in multiple cohort studies from India and globally. Symptoms overlap significantly with Long COVID: fatigue, hair loss, weight changes, and palpitations. A thyroid profile including TSH, Free T3, and Free T4 is recommended for any post-COVID patient reporting these symptoms. TSH normal range is 0.4–4 mIU/L.

Post-COVID Diseases and Complications List

Post-COVID complications span multiple organ systems. The following post-COVID diseases have been documented in Indian and global clinical studies and require active monitoring:

• Post-COVID lung disease — Post-COVID lung complications include pulmonary fibrosis, organising pneumonia, and reduced lung capacity. Breathlessness on exertion persisting beyond 4 weeks post-recovery warrants a chest X-ray, PFT (pulmonary function test), and SpO2 monitoring.
• Post-COVID cardiac complications — Myocarditis, pericarditis, arrhythmia, and increased cardiovascular risk. Elevated troponin and hs-CRP are early indicators.
• Post-COVID neurological complications — Brain fog, memory loss, peripheral neuropathy, and in severe cases, stroke. Elevated D-Dimer and homocysteine are associated with cerebrovascular risk post-COVID.
• Post-COVID renal complications — Persistent proteinuria and reduced eGFR in patients who had acute kidney injury during COVID-19.
• New-onset diabetes post-COVID — Direct beta-cell damage or steroid-induced hyperglycaemia during treatment can trigger Type 2 diabetes or pre-diabetes in previously normoglycaemic patients.
• Post-COVID thyroiditis — Subacute thyroiditis causing transient hyperthyroidism followed by hypothyroidism, presenting as fatigue, palpitations, and weight fluctuations.
• Post-COVID liver dysfunction — Elevated liver enzymes, fatty liver progression, and in rare cases, drug-induced liver injury from remdesivir or steroids used during acute treatment.
• Post-COVID haematological complications — Anaemia, thrombocytopenia, and hypercoagulability. Associated with persistent D-Dimer elevation and risk of DVT.

Watch: Post-COVID Testing and Recovery Monitoring

People Also Ask About Post-COVID Blood Tests

Post-COVID Monitoring Schedule — Tests to Repeat Every 6 Months and Annually

For patients who had COVID-19 — even mild infection — ongoing periodic blood monitoring is recommended for at least 2 years post-recovery. This is not about fear, but about catching silent changes in blood, organ function, and immunity before they become symptomatic. The following schedule is based on ICMR post-COVID clinical guidance and practices observed across Pune's post-COVID follow-up clinics.

Every 3 Months (First Year After COVID) — For Moderate to Severe Cases

Patients who were hospitalised, required oxygen, or had significant organ involvement during acute COVID-19 should repeat the following every 3 months for the first 12 months:

• Complete Blood Count (CBC) — To monitor lymphocyte recovery, platelet normalisation, and anaemia correction
• D-Dimer — Clotting activation monitoring, especially in patients with post-COVID lung or cardiac involvement
• CRP / hs-CRP — To track resolution of systemic inflammation
• Kidney Function Tests (Creatinine, eGFR) — For patients with acute kidney injury during COVID-19
• Liver Function Tests — If enzymes were deranged during acute illness or patient was on prolonged medications
• Fasting Blood Glucose and HbA1c — New-onset diabetes surveillance for all post-COVID patients, not just diabetics

Every 6 Months (All Post-COVID Patients — Mild, Moderate, and Severe)

Even patients who had mild COVID-19 managed at home should repeat the following tests every 6 months for at least 2 years. Sub-clinical organ changes can occur without symptoms and are only detectable on blood testing:

Annual Tests (Year 2 Onwards — All Post-COVID Patients)

From the second year post-COVID onwards, the monitoring interval can be extended to annually for most stable patients. The following annual panel is recommended for anyone with a prior COVID-19 infection, regardless of severity:

• Complete Blood Count — Annual immune and haematological baseline
• Kidney Function Tests — eGFR and creatinine monitoring for long-term renal health, especially in diabetics and hypertensives
• Liver Function Tests — Annual LFT to screen for post-COVID fatty liver or persistent enzyme elevation
• HbA1c + Fasting Glucose — Continued diabetes surveillance; post-COVID diabetes risk persists beyond 2 years in some cohorts
• Lipid Profile — Cardiovascular risk monitoring, particularly for patients over 40
• Vitamin D3 and B12 — Nutritional reassessment, especially if fatigue persists
• Thyroid Profile — Annual TSH to detect delayed-onset post-COVID thyroid dysfunction
• Cardiac Risk Markers Panel — hs-CRP, homocysteine, and lipids for patients with prior COVID-related chest symptoms or palpitations

In Pune and Pimpri-Chinchwad, all the above tests can be done at home through healthcare nt sickcare's home sample collection service — a single phlebotomist visit can cover the entire annual post-COVID panel, with digital reports delivered within 24–48 hours. Start with a preventive health checkup package to establish your post-COVID baseline.